centerprise, LLC – Trademark Portfolio
Entity Type: 16
centerprise, LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CENTERPRISE. The owner is based in Garrison, NY.
65 Indian Brook Road
Garrison, NY 10524
Showing of trademarks Trademarks
Trademark Classifications
centerprise, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does centerprise, LLC have?
centerprise, LLC has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 cancelled.
What trademark classes does centerprise, LLC file in?
centerprise, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 44 (Medical Services), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.
What are centerprise, LLC's most well-known trademarks?
centerprise, LLC's registered trademark portfolio includes well-known marks such as CENTERPRISE. These are among 2 currently registered trademarks in the portfolio.
What is centerprise, LLC's trademark registration success rate?
centerprise, LLC has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.